Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Anebulo Pharmaceuticals, Inc. Common Stock (ANEB)

Annual Return

Over the past 3 years, ANEB has had an average annual return of -49.25%, underperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, ANEB has had an average annual return of -47.39%, underperforming the benchmark SPY, which returned +12.73% annual.

Since May 7, 2021, ANEB has had an average annual return of -45.52%, underperforming the benchmark SPY, which returned +13.15% annual.

202620252024202320222021
-70.27%-39.86%-30.58%-0.18%-60.59%-13.38%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+3.94%-65.72%+174.95%-55.52%+6.77%-16.01%-23.92%-70.27%
2025-8.58%-24.46%+12.06%-6.94%-13.67%+37.87%+85.45%-6.38%-0%+5.60%-11.35%-56.83%-39.86%
2024+6.43%+5.62%+5.51%+1.06%-29.33%+33.18%-12.09%-20.00%+0.52%-2.58%-23.41%+16.67%-30.58%
2023+5.21%+20.77%-5.83%+0.69%-22.61%+3.99%-8.10%+29.19%+9.49%-27.98%+3.61%+6.14%-0.18%
2022+7.48%+10.29%-2.88%-47.60%-27.22%+92.58%-42.60%+16.25%-19.30%-13.95%-8.69%+10.16%-60.59%
2021+15.49%-16.82%+6.42%-7.00%-2.97%+1.53%-9.77%+2.50%-13.38%

Drawdown analysis of Anebulo Pharmaceuticals, Inc. Common Stock (ANEB)

The maximum drawdown for the ANEB was -99.99%, occurring on Jul 15, 2026. This drawdown has not yet recovered.

The current ANEB drawdown is -96.64%.

Since May 7, 2021 ANEB has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%May 21, 20211291Jul 15, 2026OngoingOngoingOngoing
-1.41%May 7, 20213May 12, 20216May 20, 20219